A team of Irish clinical academics have secured one of seven major awards that have been made across the UK and Ireland by Wellcome*. The scheme, which will be known as Wellcome – HRB Irish Clinical Academic Training Programme, will support the intake of eight postgraduate trainee doctors per year for a five-year period, providing fully integrated clinical and research training up to consultant level.
The award represents an overall investment of almost €13 million with €7.5 million coming from Wellcome and the Health Research Board (HRB ). This is matched with a further combined contribution of €5.5 million from the Health Service Executive and the Health and Social Care Research and Development Office, Northern Ireland, and the partner universities.
The programme will be open to applications in autumn 2016 for an intake beginning in July 2017.
“A research-active health system is proven to have better outcomes for patients”, said Minister for Health Simon Harris, announcing the programme today. “Patients will be the long-term winners as this collaborative investment will fundamentally improve both the number and calibre of Clinician Scientists working in our universities and health services. I’m really pleased to announce this significant investment in the future of the health service, and I know the positive impact for patient care is going to be very real. I very much look forward to seeing this important programme in action over the next few years.
I welcome the strong collaboration that is core to this research award, and I am particularly pleased that Northern Ireland is part of it, making this an all island and multi-institutional Programme.”
The north’s Health Minister, Michelle O Neill said; “This is the largest ever investment in academic medicine through an all island collaborative partnership and it will make a real difference to the health of people across the island of Ireland and further afield. I want to congratulate all those involved in securing this programme and in particular pay tribute to the role played by Professor Peter Maxwell, from Queen’s University in Belfast. This initiative demonstrates what can be achieved through collaborative working across the whole island of Ireland.”
The partner universities involved in the programme include NUI Galway, Trinity College Dublin, University College Dublin, University College Cork, Royal College of Surgeons in Ireland and Queen’s University Belfast. Each academic partner is affiliated to hospitals and hospital groups in their region. A crucial coordinating role was played by Molecular Medicine Ireland, the collaborative entity owned by the university partners.
Lead investigators from the Institutions involved in the application include:
Professor Conall Dennedy, NUI Galway, Co-investigator, Wellcome-HRB Irish Clinical Academic Training Programme
Professor Michael Gill, Trinity College Dublin, Director of the Wellcome-HRB Irish Clinical Academic Training Programme
Professor Paddy Mallon, University College Dublin, Deputy Director of the Wellcome-HRB Irish Clinical Academic Training Programme
Professor Joe Eustace, University College Dublin, Co-investigator, Wellcome-HRB Irish Clinical Academic Training Programme
Professor Ray Stallings, RCSI, Co-investigator, Wellcome-HRB Irish Clinical Academic Training Programme
Professor Peter Maxwell, Queen’s University Belfast, Co-investigator, Wellcome-HRB Irish Clinical Academic Training Programme
Dr Mark Watson, Molecular Medicine Ireland, Co-ordinator of the application for the Wellcome-HRB Irish Clinical Academic Training Programme
Professor Conall Dennedy, NUI Galway, Co-investigator, Wellcome-HRB Irish Clinical Academic Training Programme, said: “This marks a fantastic opportunity for medical trainees to develop careers as clinician scientists through a truly integrated, collaborative programme which incorporates the major medical schools across the entire island, North and South. This programme demonstrates how we can work together across academic, training and healthcare institutions. Through these collaborations we will strengthen our research network across the country, train excellent clinician scientists and ultimately benefit the patients across the island by sowing the seeds to develop a landsacpe for cutting edge medicine, technology transfer and translational medicine. We all look forward to our first intake of trainees in 2017.”
